Viyash Scientific share news and announcements
NSE: VIYASHBSE: 512529Pharmaceuticals & BiotechnologySmall Cap
Formerly Sequent Scientific
Last close ₹204.18down ₹3.81 (1.83%)BSE ₹203.45
Share price at the NSE close on 23 Oct 2026. Previous close ₹207.99.
52-week range of traded prices to 23 Oct 2026
₹178.13Low, 23 Mar 2026₹298.00High, 6 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9,017 Cr598th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 11.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 44,68,18350.3% delivered
Viyash Scientific share news and announcements
593 announcements, routine notices left out, newest first. Page 11 of 12.
Sep 2018
Aug 2018
21 Aug · Legal
The exchange asked on 20 Aug 2018
10 Aug · Board meeting
9 Aug · Board meeting
Jul 2018
Jun 2018
May 2018
24 May · Board meeting
Apr 2018
Mar 2018
Feb 2018
27 Feb · Legal
Exchange has sought clarification from Sequent Scientific Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Board meeting notice not submitted. The response of the Company is awaited.
Jan 2018
Dec 2017
Nov 2017
9 Nov · Board meeting
Oct 2017
Sep 2017
Aug 2017
Jul 2017